Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Haedal Protocol (HAEDAL) vs Mitosis (MITO) Price & Performance

Haedal ProtocolTrade
MitosisTrade

Price performance (Past 24H)

Key statistics

Haedal Protocol vs Mitosis — how do they compare? Haedal Protocol trades at Rp294.53 (market cap Rp133,79M, Rp20,91M 24h volume), while Mitosis trades at Rp393.43 (market cap Rp71,07M, Rp65,59M 24h volume). The key difference: Haedal Protocol is the larger of the two by market cap, and Haedal Protocol's circulating supply is 454,2M / 1B HAEDAL (46%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Haedal Protocol for 14 Days and Mitosis for 19 Days on average.

HAEDALMITO
Market Cap
Rp133,79MRp71,07M
Volume (24h)
Rp20,91MRp65,59M
Circulating Supply
454,2M / 1B HAEDAL (46%)181,3M / 1B MITO (19%)
Typical Hold Time
14 Days19 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Haedal Protocol

Haedal Protocol currently trades at Rp294.53 with a market cap of Rp133.55M, showing bearish technical signals overall. The asset sits near its pivot point of Rp295, with immediate support at Rp286 and resistance at Rp306. With 46% of the 1M max supply in circulation and average hold time of 14 days, the token displays moderate distribution. No recent protocol updates or major ecosystem developments were identified.

The outlook remains cautious with bearish technical indicators outweighing neutral oscillators. Key opportunities include potential bounce from support levels, while risks include limited liquidity and the dominant bearish trend. Investors should monitor for protocol developments and increased trading volume to confirm any trend reversal.

Mitosis

MITO is trading at Rp385.97 with a bearish technical signal, as moving averages indicate strong selling pressure while oscillators remain neutral. The token has a market cap of Rp70.05 million and a low circulation rate of 19%, with key support at Rp352 and resistance at Rp395. Recent news highlights a corporate acquisition of a similarly named entity, but no direct protocol updates were found for the cryptocurrency.

Overall outlook is cautious due to bearish technicals and limited fundamental developments. Key opportunities include potential recovery if support holds, but risks involve low liquidity and minimal ecosystem activity. Investors should monitor for any token-specific news or network updates to reassess positioning.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HAEDAL
56% Buy44% Sell
Avg holding period · 14 Days
MITO
2% Buy98% Sell
Avg holding period · 19 Days

About Haedal Protocol

Haedal is a leading liquid staking protocol built specifically on the Sui blockchain. It provides a reliable infrastructure that enables users to stake their SUI and Walrus tokens with validators, allowing them to earn ongoing consensus rewards. Additionally, users can unlock liquidity in the form of liquid staking tokens (LST), which can be utilized across decentralized finance (DeFi) applications. Haedal's goal is to become the primary platform for staking and earning within the Sui ecosystem.

Read more on HAEDAL

About Mitosis

Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.

Read more on MITO